(0) items in cart / view cart / checkout  
 
  Chemicals
  Company Profiles
  Country Analyses
  Energy and Utilities
  Food & Beverage
  In Vitro Diagnostics
  Medical Devices
  Pharmaceuticals & Biotechnology
 
 
  Advertising
Aerospace, Defense
Automotive
Banking
Biotechnology
Business Services
Chemicals
Company Reports
Construction
Consumer Goods
Countries
Diagnostics
Energy, Environment
Food & Beverages
Government
Healthcare
IT
Manufacturing
Media
Medical Devices
Pharmaceuticals
Retailing
Sales & Marketing
Sourcing
Telecommunications
Transportation
Travel, Entertainment
 
Home > In Vitro Diagnostics >  POC Testing
 
 POC Testing Market Research Reports
Title

To order sections of the reports, contact Client Services.

Price
« Previous  6  7  8  9  10  11  12  13  14  15  Next »
Bilirubin: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA

This new report from Venture Planning Group provides analysis of Bilirubin testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.

 

$750.00
       
BUN (Blood Urea Nitrogen): 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA

This new report from Venture Planning Group provides analysis of BUN (Blood Urea Nitrogen)testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.

 

$750.00
       
Calcium: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA

This new report from Venture Planning Group provides analysis of Calcium testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.

 

$750.00
       
Carbon Dioxide/Bicarbonate: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations France, Germany, Italy, Japan, Spain, UK, USA

This new report from Venture Planning Group provides analysis of Carbon Dioxide/Bicarbonate testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.

 

$750.00
       
Chloride: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA

This new report from Venture Planning Group provides analysis of Chloride testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.

 

$750.00
       
Cholesterol: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA

This new report from Venture Planning Group provides analysis of Cholesterol testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.

 

$750.00
       
Creatine Kinase (CK): 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA

This new report from Venture Planning Group provides analysis of Creatine Kinase (CK) testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.

 

$750.00
       
CK-MB: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA

This new report from Venture Planning Group provides analysis of CK-MB testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.

 

$750.00
       
Creatine: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA

This new report from Venture Planning Group provides analysis of Creatine testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.

 

$750.00
       
GGT: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA

This new report from Venture Planning Group provides analysis of GGT testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.

 

$750.00
       
Glucose: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA

This new report from Venture Planning Group provides analysis of Glucose testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.

 

$750.00
       
HDL Cholesterol: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA

This new report from Venture Planning Group provides analysis of HDL Cholesterol testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.

 

$750.00
       
Homocysteine: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA

This new report from Venture Planning Group provides analysis of Homocysteine testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.

 

$750.00
       
Iron: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA

This new report from Venture Planning Group provides analysis of Iron testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.

 

$750.00
       
LDH: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA

This new report from Venture Planning Group provides analysis of LDH testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.

 

$750.00
       
Magnesium: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA

This new report from Venture Planning Group provides analysis of Magnesium testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.

 

$750.00
       
Phosphorus: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA

This new report from Venture Planning Group provides analysis of Phosphorus testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.

 

$750.00
       
Potassium: 2013-2018 Test Volume and Sales Forecasts by Country and Market Segment: Hospitals, Commercial Labs, POC Locations--France, Germany, Italy, Japan, Spain, UK, USA

This new report from Venture Planning Group provides analysis of Potassium testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment.

 

$750.00
       
« Previous     6  7  8  9  10  11  12  13  14  15   Next »
 
VPGMarketResearch.com © Copyright 2015. all rights reserved. Web Design by Spida Design  
  Close  X